Skip to main content
. 2022 Jun;11(6):1027–1037. doi: 10.21037/tlcr-22-376

Figure 6.

Figure 6

Kaplan-Meier curves of PFS and OS by driver gene alteration status. (A,B) The patients without gene alterations had better PFS and OS than those of patients with gene alterations (mPFS 5.5 vs. 3.5 months, P=0.001; mOS 16.1 vs. 13.9 months, P=0.012). mPFS, median progression-free survival; mOS, median overall survival.